Skip to main content
SpringerLink
Log in

Bevacizumab: further evidence of risks in breast cancer patients

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FAB.Congestive heart failure risk in patients with breast cancer treated with bevacizumab. Journal of Clinical Oncology: [7 pages], 18 Jan 2011. Available from: URL: http://dx.doi.org/10.1200/JCO.2010.31.9129

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab: further evidence of risks in breast cancer patients. React. Wkly. 1336, 3 (2011). https://doi.org/10.2165/00128415-201113360-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113360-00005

Keywords

Search

Navigation